GINA 2024 clarifies that assessment of symptom control should not be limited to the last 4 weeks, and emphasizes that assessing symptom control is not enough. Risk factors for exacerbations, including past exacerbations, must also be assessed. ginasthma.org/reports

GINA 2024 provides recommendations about cough variant asthma which may be difficult to distinguish from other causes of chronic cough, since spirometry may be normal - treatment is the same as for asthma in general, with ICS-containing treatment. See ginasthma.org/reports

World No Tobacco Day 2024

Today on #WorldNoTobaccoDay FIRS is highlighting the dangers of novel tobacco products aimed at youth and condemns the tobacco industry's predatory marketing tactics.

For more information, visit: ginasthma.org/world-no-tobac…

GINA UPDATE: an update of the GINA 2024 report was published on 22 May 2024, as we became aware that some medication doses for anti-inflammatory reliever therapy in Box 4-8 were being misread. Download the latest version from ginasthma.org/reports. Please share.

The 2024 GINA diagnostic flowchart for clinical practice has been revised.  Many health professionals don’t have access (or timely access) to spirometry. While less reliable than spirometry peak expiratory flow is better than relying on symptoms alone. ginasthma.org/reports

The goal of asthma treatment should be personalized for each patient, aiming for the patient’s best possible long-term outcomes. This includes both long-term symptom control and long-term risk reduction. Assessing recent symptom control is not enough. ginasthma.org/reports/

The goal of asthma treatment should be personalized for each patient, aiming for the patient’s best possible long-term outcomes. This includes both long-term symptom control and long-term risk reduction. Assessing recent symptom control is not enough. ginasthma.org/reports/

Today is World Asthma Day! GINA emphasizes the need to empower people with asthma with the appropriate education to manage their disease - Asthma Education Empowers.

Download the new 2024 report here: ginasthma.org/2024-report/

#WorldAsthmaDay #GINA #Asthma #Asthma Education

Track 1 the preferred GINA approach reduces the risk of severe asthma exacerbations compared with using a SABA reliever while achieving similar symptom control, similar lung function, and a lower oral corticosteroid burden.
See  ginasthma.org/reports/

GINA asthma adult and adolescent treatment is divided into two tracks. Track 1, with ICS-formoterol reliever, is recommended by GINA because it reduces the risk of severe asthma exacerbations compared with using a SABA reliever and is simpler. See ginasthma.org/reports/

Prof Guy Brusselle President of the Belgian Respiratory Society spoke at EU Parliament on
Lack of approval of “ICS-formoterol as needed in GINA steps 1 and 2” by the European Medicines Agency (EMA) - a major obstacle in implementing the GINA guidelines in the EU (27 countries.

GINA members presented at the European Parliament meeting, aiming for better asthma care and patient outcomes in Europe and beyond. #GINA #Asthma

Please share this recommendation from GINA: Adults and adolescents with #MILD #asthma should be treated with inhaled corticosteroid (ICS) containing therapy either regularly every day or with low-dose ICS–formoterol taken as needed for symptom relief. See ginasthma.org/reports/

#Asthma in adults, adolescents and children 6–11 years should not be managed with short-acting β2-agonist relievers (SABAs) alone. Inhaled corticosteroid (ICS)-containing therapy reduces the risk of severe exacerbations, and controls symptoms. See ginasthma.org/reports/

Please share this ‘bite sized’ message from Global Initiative for Asthma (GINA) PCRS RCPCH RCGP NPRANG The RCN plɐuoᗡɔW ʎɹɹɐ⅁🅾️ 🏴󠁧󠁢󠁳󠁣󠁴󠁿 🇺🇦 💙 Asthma Society of Ireland Family Allergy & Asthma Care Asthma.ca

GINA recommends regularly assessing multimorbidity in people with asthma. Conditions such as rhinitis, sinusitis, gastro-oesophageal reflux, obesity, obstructive sleep apnoea, depression and anxiety, if not treated, can contribute to poor asthma control.
bit.ly/436r063

Please share this weeks message from Global Initiative for Asthma (GINA). IPCRG PCRS Asthma + Lung UK NPRANG RCGP RCPCH

GINA recommends regularly assessing asthma treatment issues:
Record the patient’s current treatment, inhaler technique, adherence, patient attitudes and goals, and provide or amend a written asthma action plan.

It’s not enough to only ask about drugs. bit.ly/436r063

GINA recommends assessing asthma control in two domains:
They are symptom control and risk factors for future attacks, including having had an attack in the previous year. It’s not enough to only ask about recent symptom control. bit.ly/436r063

An asthma attack is a signal that something went wrong! 4 of 4: 
Was a post-attack review done? GINA recommends an assessment within a week to identify and fix modifiable risk factors such as lack of an asthma action plan. ginasthma.org/reports